Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alina Panainte"'
Autor:
Alexandru Sava, Frederic Buron, Sylvain Routier, Alina Panainte, Nela Bibire, Sandra Mădălina Constantin, Florentina Geanina Lupașcu, Alin Viorel Focșa, Lenuţa Profire
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 7079 (2021)
Starting from indomethacin (IND), one of the most prescribed non-steroidal anti-inflammatory drugs (NSAIDs), new nitric oxide-releasing indomethacin derivatives with 1,3,4-oxadiazole-2-thiol scaffold (NO-IND-OXDs, 8a–p) have been developed as a saf
Externí odkaz:
https://doaj.org/article/b5e62356e5ff4d23a24f8cdc49b850ec
Autor:
Nela Bibire, Florentina Lupașcu, Sylvain Routier, Frédéric Buron, Sandra Constantin, Alexandru Sava, Alin Viorel Focșa, Lenuţa Profire, Alina Panainte
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7079, p 7079 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 13
International Journal of Molecular Sciences
Volume 22
Issue 13
Starting from indomethacin (IND), one of the most prescribed non-steroidal anti-inflammatory drugs (NSAIDs), new nitric oxide-releasing indomethacin derivatives with 1,3,4-oxadiazole-2-thiol scaffold (NO-IND-OXDs, 8a–p) have been developed as a saf
Autor:
Liliana Lacramioara Pavel, Liliana Tartau, Gratiela Eliza Popa, Catalina Elena Lupusoru, Ciprian Rezus, Cristiana Filip, Alina Panainte, Maria Bogdan, Alin Constantin Pinzariu, Beatrice Rozalina Buca, Raoul Vasile Lupusoru, Elena Rezus
Publikováno v:
Revista de Chimie. 69:2899-2903
We aimed to investigate the effects of two nitric oxide donors in acute inflammation in rats. The experiment was carried out on white Wistar rats, randomly distributed in 4 groups of 5 animals each; the substances were administered intraperitoneally
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 139, Iss, Pp 111678-(2021)
In this study we present design and synthesis of nineteen new nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold (NO-IND-TZDs) (6a-s), as a new safer and efficient multi-targets strategy for inflammatory diseases. Th